Molecular Trigger Identified in Common Tendon Injuries

Painful tendon injuries, including Achilles tendon pain, tennis elbow, swimmer’s shoulder, and jumper’s knee, affect both athletes and older adults. Researchers have now pinpointed a key molecular driver, the HIF1 protein, that actively causes damaging structural changes in tendons, rather than simply being a consequence of the injury.

The Common Thread in Tendinopathies

These conditions, collectively known as tendinopathies, are among the most frequent reasons people seek care from orthopedic specialists. Despite their varied locations, they share a common cause: repeated strain on tendons, leading to inflammation and pain. Tendons, which connect muscle to bone, are particularly vulnerable to overuse due to the concentrated forces they endure during movement.

HIF1: The Newly Identified Molecular Driver

A research team at ETH Zurich, led by Jess Snedeker and Katrien De Bock, identified the protein HIF1 as a central driver of tendon disease. Even as previously known to be present at elevated levels in diseased tendons, it was unclear if this increase was a cause or effect. Experiments in mice and with human tendon tissue revealed that activating HIF1 permanently led to tendon disease, even without overloading. Conversely, deactivating HIF1 protected tendons, even under heavy strain.

How HIF1 Damages Tendons

Elevated HIF1 levels cause a pathogenic remodeling of tendons. Specifically, more crosslinks form within the collagen fibers that make up the tendon’s structure, making them more brittle and impairing their mechanical function. Blood vessels and nerves grow into the tendon tissue, potentially explaining the pain commonly associated with tendinopathy.

Implications for Treatment

The discovery of HIF1 as a key driver highlights the importance of early treatment for tendon problems, particularly in young athletes. While physiotherapy can provide relief, damage caused by HIF1 can accumulate and grow irreversible over time, potentially requiring surgical removal of the diseased tendon.

Future Research and Potential Therapies

Researchers are now exploring potential therapies that could deactivate HIF1, preventing or curing tendon disease. However, directly switching off HIF1 throughout the body could lead to side effects, as it plays a crucial role in detecting oxygen levels and initiating physiological adaptation in many organs. Future research will focus on methods to specifically target HIF1 in tendon tissue or identify other molecules influenced by HIF1 that could be more suitable treatment targets. ,

Understanding Tendonitis and Overuse Injuries

Overuse injuries, like those affecting tendons, occur when the breakdown of tissue happens faster than the body’s ability to rebuild it. Common examples include tennis elbow, golfer’s elbow, jumper’s knee, and Achilles tendonitis. These conditions often start as inflammation (tendonitis) but can progress to more serious conditions involving scar tissue buildup (tendonosis).